IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces An Investigation Of Claims Against ERBA Diagnostics, Inc. And Encourages Shareholders To Contact The Firm

LOS ANGELES--()--Goldberg Law PC ( announces that it is investigating claims of potential misrepresentations by ERBA Diagnostics, Inc. (“ERBA” or the “Company”) (NYSE MKT: ERB). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased or otherwise acquired ERBA shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at, or by email at

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. On November 16, 2015, ERBA announced it would delay filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 citing its continued “efforts to improve the effectiveness of its internal control over financial reporting.” Then on November 20, 2015, the Company announced that the Audit Committee of the Board of Directors had determined that the financial statements for the years ended December 31, 2013 and 2014 and for each of the interim periods ended March 31, 2015 and June 30, 2015 should no longer be relied upon. When the truth was revealed, shares dropped causing investors harm.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at, or email us at

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.